A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier ...

New research exposes the molecular switches that let some cancers shapeshift and reveals how they might finally be stopped. Certain cancers are extremely difficult to treat, and carcinomas are among ...

Lung cancer in never smokers is an increasingly recognized global health issue with distinct biological drivers, environmental risk factors, and genetic susceptibilities. Improved risk modelling, ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

Background: Colorectal cancer (CRC) remains a major global health burden, particularly when complicated by pulmonary metastasis (PM), which significantly worsens prognosis and reduces survival despite ...

Circulating tumor DNA may be an effective biomarker for stratifying patients with small cell lung cancer who would benefit from more stringent follow-ups and clinical trial participation.Patients who ...

A landmark global study suggests that tobacco smoking, infection and alcohol consumption are the leading causes of ...

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...

SCLC diagnosis involves imaging, biopsies, and lab tests to assess tumor spread and guide treatment decisions. Treatment options vary by stage, with surgery, chemotherapy, radiation, and immunotherapy ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a treatment could be difficult. By Gina Kolata Is there a way to use the body’s ...